β-Amyloid 22-35
98%
- Product Code: 64117
CAS:
144189-71-9
| Molecular Weight: | 1403.62 g./mol | Molecular Formula: | C₅₉H₁₀₂N₁₆O₂₁S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
Used in research to study Alzheimer's disease, particularly focusing on the aggregation and neurotoxicity of amyloid peptides. It helps in understanding the mechanisms of amyloid plaque formation, which is crucial for developing therapeutic strategies. The peptide is also employed in screening potential inhibitors of amyloid aggregation, aiding in the discovery of drugs that could prevent or slow down the progression of Alzheimer's. Additionally, it serves as a model in biochemical assays to explore the interactions between amyloid peptides and other biomolecules, providing insights into the pathological processes involved in neurodegenerative diseases.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | WHITE POWDER |
| PURITY | 97.5-100 |
| SOLUBILITY | CLEAR COLORLESS SOLUTION AT 1 MG/ML IN WATER |
| Infrared spectrum | Conforms to Structure |
| NMR | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | ฿8,160.00 |
+
-
|
| 0.005 | 10-20 days | ฿32,600.00 |
+
-
|
| 0.010 | 10-20 days | ฿55,600.00 |
+
-
|
β-Amyloid 22-35
Used in research to study Alzheimer's disease, particularly focusing on the aggregation and neurotoxicity of amyloid peptides. It helps in understanding the mechanisms of amyloid plaque formation, which is crucial for developing therapeutic strategies. The peptide is also employed in screening potential inhibitors of amyloid aggregation, aiding in the discovery of drugs that could prevent or slow down the progression of Alzheimer's. Additionally, it serves as a model in biochemical assays to explore the interactions between amyloid peptides and other biomolecules, providing insights into the pathological processes involved in neurodegenerative diseases.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :